Bloomberg News is looking for an ambitious news breaker to cover the biggest US drug companies: Pfizer, J&J, Bristol-Myers and Merck, which are all in various stages of trying to reinvent themselves as some of their blockbuster drugs face generic competition later this decade.
You are an experienced and versatile reporter who can break news on dynamic and evolving corporate stories, analyze and translate scientific research and breakthroughs, and keep tabs on the enormous power the pharma industry wields as the largest industry lobby in Washington. You are motivated by scoops and the ability to conceive and execute ambitious enterprise and investigative projects that map out the future of big pharma.
To apply, go here.
Ken Brown of The Wall Street Journal is leaving the news organization. He is an…
Dow Jones News Fund President Brent W. Jones announced at the nonprofit journalism training organization’s…
Jillian Ward, managing editor for U.S. technology at Bloomberg News, sent the following note to…
Rick Berke, a co-founded and executive editor of STAT News, writes about the importance of…
Thomas Maxwell has joined Gizmodo as a tech reporter. He previously was at Business Insider covering…
Banking Times has acquired the domain name "The New Fiver" for an undisclosed amount, aiming…